Capital Market Strategies’s Eli Lilly LLY Stock Holding History

Capital Market Strategies’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$1.13M	Sell	1,446 -1,826	-56%	-$1.42M	0.78%	27
2025 Q1	$2.7M	Sell	3,272 -246	-7%	-$205K	1.8%	12
2024 Q4	$2.72M	Buy	3,518 +48	+1%	+$39.7K	1.56%	12
2024 Q3	$3.07M	Buy	3,470 +1	+0%	+$899	1.85%	9
2024 Q2	$3.14M	Buy	3,469 +45	+1%	+$36K	1.98%	8
2024 Q1	$2.66M	Sell	3,424 -26	-0.8%	-$18.5K	2.03%	9
2023 Q4	$2.01M	Buy	3,450 +275	+9%	+$161K	1.75%	9
2023 Q3	$1.67M	Buy	3,175 +59	+2%	+$30.4K	1.66%	10
2023 Q2	$1.46M	Buy	+3,116	New	+$1.31M	1.35%	12
2023 Q1	–	Sell	-3,096	Closed	-$1.13M	–	91
2022 Q4	$1.13M	Hold	3,096	–	–	1.22%	17
2022 Q3	$1M	Buy	3,096 +55	+2%	+$17.4K	1.13%	23
2022 Q2	$986K	Sell	3,041 -7	-0.2%	-$2.1K	1.03%	23
2022 Q1	$873K	Sell	3,048 -22	-0.7%	-$5.66K	0.75%	32
2021 Q4	$848K	Buy	+3,070	New	+$778K	0.7%	36

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Capital Market Strategies's LLY Position: Q2 2025 in Review

Capital Market Strategies reduced its Eli Lilly (LLY) stake by 56% in Q2 2025, selling an estimated $1.42M and leaving 1,446 shares worth $1.13M. The position accounts for 0.78% of the portfolio, ranked #27.

Capital Market Strategies first reported a position in LLY in Q4 2021 and has held it in 14 quarters since. The position peaked at $3.14M in Q2 2024. 3,914 funds tracked by Wall St. Rank hold LLY as of Q2 2025.

Capital Market Strategies held 1,446 shares of Eli Lilly worth $1.13M as of Q2 2025.
Capital Market Strategies sold 1,826 Eli Lilly shares in Q2 2025, an estimated $1.42M.
Eli Lilly made up 0.78% of Capital Market Strategies's portfolio in Q2 2025, its #27 holding.
Capital Market Strategies first reported a position in Eli Lilly in Q4 2021 and has held it in 14 quarters since.
Capital Market Strategies's Eli Lilly position peaked at $3.14M in Q2 2024.
3,914 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2025.

Based on Capital Market Strategies's 13F filing for Q2 2025, filed 2 Jul 2025.